Skip to main content

Table 3 Population characteristics and imaging parameters in subgroups

From: Assessment of right ventricular size and function from cardiovascular magnetic resonance images using artificial intelligence

Parameters

Median (interquartile range) or n (%)

Clinical

RVEF ≤ 35% (n = 11)

RVEF35-50% (n = 21)

RVEF ≥ 50% (n = 68)

Gender, male

6 (55%)

15 (71%)

38 (56%)

Age, years

59 (51–80)

63 (50–69)

61 (54–69)

Body mass index, kg/m2

29 (25–38)

26 (23–31)

29(25–32)

Body surface area, m2

2.0 (1.8–2.4)

1.9 (1.7–2.2)

2.0 (1.8–2.1)

Race, %

   

 Black

8 (73%)

9 (43%)

25 (37%)

 White

2 (18%)

11 (52%)

31 (46%)

 Hispanic

1 (9%)

0 (0)

6 (9%)

 Asian

0 (0)

0 (0)

5 (7%)

 Unknown

0 (0)

1 (5%)

1 (2%)

Diagnosis, n (%)

   

 Coronary artery disease

4 (36%)

10 (48%)

42 (62%)

 Hypertension

8 (73%)

17 (81%)

56 (82%)

 Diabetes

6 (55%)

7 (33%)

29 (43%)

 Post-heart transplant

0 (0)

1 (5%)

4 (6%)

 Post-CABG

2 (18%)

2 (10%)

15 (22%)

 Congenital heart disease

0 (0)

0 (0)

2 (3%)

 Pulmonary hypertension

1 (9%)

3 (14%)

3 (4%)

 Chronic lung disease

0(0)

11 (52%)#

14 (21%)

 OSA

1 (9%)

1(5%)

12 (18%)

 Cardiomyopathy

10 (91%)*

12 (57%)#

17 (25%)

 ICM

4 (36%)*

4 (19%)

8 (12%)

 NICM

6 (55%)*

8 (38%)#

9 (13%)

CMR

   

 LVEDV, ml

238 (179–310)*

166 (136–218)

147 (116–192)

 LV DVI, ml/m2

124 (85–139)*

97 (74–124)#

71 (64–97)

LVESV, ml

176 (128–234)*

111 (72–134)#

65 (47–100)

 LVESVI, ml/m2

93 (62–105)*

55 (38–75) #

32 (24–52)

 LVM, g

115 (103–226) *

125 (107–140)#

101 (83–122)

 LVMI, g/m2

62 (54–93)*

66 (54–76)#

52 (44–61)

 LVEF, %

27 (22–30)*

43 (36–47)#

54 (44–63)

 RVEDV, ml

190 (148–224)*

164 (124–191)

134 (113–164)

 RVEDVI, ml/m2

87 (74–115)*

85 (74–95)#

71 (61–81)

 RVESV, ml

131 (108–161)*

95 (75–112)#

59 (46–73)

 RESVI, ml/m2

65 (54–77)*

50 (42–54)#

30 (25–36)

 RV EF, %

27 (26–32)*

43 (40–46)#

58 (53–61)

 LGE, n (%)

8 (73%)*

9(43%)

26 (38%)

 Ischemic pattern

1 (9%)*

6 (29%)

22 (32%)

 Non-ischemic pattern

5 (46%)*

2 (10%)

3 (4%)

 Both patterns

2 (18%)

1 (5%)

1 (2%)

  1. ICM ischemic cardiomyopathy, LGE late gadolinium enhancement, LVEDV left ventricular end-diastolic volume, LVEDVI left ventricular end-diastolic volume index, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVESVI left ventricular end-systolic volume index, LVM left ventricular mass, LVMI left ventricular mass index, NICM non-ischemic cardiomyopathy, RVEDV right ventricular end-diastolic volume, RVEDVI right ventricular end-diastolic volume index, RVEF right ventricular ejection fraction, RVESV right ventricular end-systolic volume, RVESVI right ventricular end-systolic volume index
  2. P < 0.05, RVEF ≤ 35% and RVEF 35–50%
  3. *P < 0.05, RVEF ≤ 35% and RVEF ≥ 50%
  4. #P < 0.05, RVEF 35–50% and RVEF ≥ 50%